Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Suture-Based Percutaneous Closure vs. Plug for Large Arteriotomies

This research was designed to test the superiority of plug-based vs. suture-based vascular closure devices in large arteriotomies, such as transcatheter aortic valve replacement (TAVR).

Cierre con sutura o plug

Vascular complications from TAVR are relevant and, in many cases, derive from problems with the closure device.

The MASH (MANTA vs. Suture-based vascular closure after transcatheter aortic valve replacement) study was conducted in two centers, where patients undergoing TAVR were randomized to the MANTA device vs. 2 ProGlides.

The primary endpoint was a composite of major and minor access-related complications. The secondary endpoint included clinically relevant access-site bleeding, time to hemostasis, and device failure (not achieving hemostasis within 5 minutes or requiring an additional maneuver, such as stenting, surgery, or another device).

Between 2018 and 2020, 210 patients were enrolled (mean age: 81; mean STS: 2.7%).


Read also: Should We Discontinue Anticoagulation Before TAVR?


There were no differences in vascular complications between MANTA and ProGlide (10% vs. 4%; p = 0.16). Furthermore, clinically relevant bleeding rates were similar (9% vs. 6%, respectively, p = 0.57).

Device failure was less frequent with the MANTA device (20% vs. 40%, p < 0.001). To fix that issue, MANTA usually required surgery or a covered stent, while ProGlide could frequently solve the vascular complication with an additional closure device.

Conclusion

The plug-based vascular percutaneous closure device was similar in terms of vascular complications and bleeding compared with a suture-based device.

Device failure was lower with MANTA, but rescue maneuvers when needed were different that those required by the ProGlide.

Original title: Suture- or Plug-Based Large-Bore Arteriotomy Closure. A Pilot Randomized Controlled Trial.

Reference: Maarten P. van Wiechen et al. J Am Coll Cardiol Intv 2021, article in press.https://doi.org/10.1016/j.jcin.2020.09.052.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

TAVI has become the standard treatment for high-risk aortic stenosis. When transfemoral access is not feasible (approximately 10–15%), alternative approaches are used: transaxillary (subclavian...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...